• Profile
Close

Premature ovarian insufficiency and early depletion of the ovarian reserve in the monogenic Mulibrey nanism disorder

Human Reproduction Jun 08, 2018

Karlberg S, et al. - Researchers investigated the timing of onset and clinical course of premature ovarian insufficiency (POI) in patients with Mulibrey nanism (MUL), a monogenic disorder caused by mutations of the peroxisomal TRIM37 gene. Infant and young MUL girls already display a highly reduced number of ovarian follicles. The majority of these patients would have early depletion of follicles resulting in clinical and biochemical signs of POI.

Methods

  • In 33 MUL patients [aged 5.1–47.3 years (median age 22.3) at the end of observation], the gonadal function, pubertal development and ovarian reserve were studied.
  • Between 2004 and 2014, they followed the patients and enrolled 19 pubertal or postpubertal patients in a cross-sectional study.
  • Longitudinal assessment was performed of the period of postnatal activation of the hypothalamic–pituitary–gonadal axis (minipuberty), pubertal development and menstrual history.
  • In this cross-sectional study, they performed gynecological examination, analysis of reproductive hormones and ultrasonography with evaluation of ovarian volume and antral follicle count.

Results

  • A transient minipuberty with a high FSH surge was observed in infant girls.
  • Gonadotropins were normal or slightly elevated in childhood, but these began to rise to hypergonadotropic levels in prepuberty.
  • Throughout childhood, undetectable or low anti-müllerian hormone (AMH) levels were noted.
  • Spontaneous onset of puberty occurred; the median age at menarche was 12.5 years.
  • Regular menses was never attained in 54% of the patients; only 8% of the women menstruated regularly 10 years from menarche.
  • In the cross-sectional study, ultrasonography revealed normal ovarian morphology in none of the patients.
  • Ovaries were hypoplastic; no or fewer than two visible antral follicles were noted in 82%.
  • The vast majority (89%) demonstrated undetectable AMH levels.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay